Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Archives of Biochemistry and Biophysics|June 2, 2010
Kinetic characterization of the Escherichia coli oligopeptidase A (OpdA) and the role of the Tyr(607) residueRicardo Z Lorenzon, Carlos E L Cunha, Marcelo F Marcondes, et al.Medical Mycology|July 7, 2011
Identification of a metallopeptidase with TOP-like activity in Paracoccidioides brasiliensis, with increased expression in a virulent strainEllen T Gravi, Thaysa Paschoalin, Bianca R Dias, et al.Biochemical Pharmacology|August 4, 2015
Pharmacological Activities and Hydrolysis by Peptidases of [Phospho-Ser(6)]-Bradykinin (pS(6)-BK)Diego M Assis, Luiz Juliano, Thaysa Paschoalin, et al.Parasitology International|December 31, 2017
Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4Pollyana M S Melo, Sarah El Chamy Maluf, Mauro F Azevedo, et al.Neoplasia (New York, N.Y.)|January 31, 2008
Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesinElaine G Rodrigues, Andrey Ss Dobroff, Clarissa F Cavarsan, et al.Biological Chemistry|March 23, 2010
Plasminogen hydrolysis by cathepsin S and identification of derived peptides as selective substrate for cathepsin V and cathepsin L inhibitorLarissa P Coppini, Nilana M T Barros, Marcela Oliveira, et al.Biological Chemistry|June 30, 2009
Catalytic properties of recombinant dipeptidyl carboxypeptidase from Escherichia coli: a comparative study with angiotensin I-converting enzymeCarlos Eduardo L Cunha, Helena de Fátima Magliarelli, Thaysa Paschoalin, et al.Biochemical and Biophysical Research Communications|March 19, 2013
Human tissue kallikreins 3 and 5 can act as plasminogen activator releasing active plasminLucas R de Souza, Pollyana M Melo, Thaysa Paschoalin, et al.The Journal of Biological Chemistry|March 21, 2013
The impaired viability of prostate cancer cell lines by the recombinant plant kallikrein inhibitorJoana Gasperazzo Ferreira, Paula Malloy Motta Diniz, Cláudia Alessandra Andrade de Paula, et al.Cancer Chemotherapy and Pharmacology|July 2, 2025
Peptides derived from the POU domain of BRN2 show antitumor activity against murine melanoma model cells in vitro and in vivoMaria Carolina Mariano Cesar, Agnes Kobayashi Calvo de Sant'ana, Renato Arruda Mortara, et al.Pageof 3